MGC Pharmaceuticals (ASX:MXC)
Company Profile
MGC Pharmaceuticals (ASX:MXC) has changed its name to Argent Biopharma – RGT (ASX: RGT).
Below are the previous articles from MGC Pharmaceuticals (ASX:MXC):
RELATED STOCKHEAD STORIES
Rise and Shine: Everything you need to know before the ASX opens
Why these ASX firms are shying away from the ‘pot stock’ label – Part One
In Case You Missed It: TechGen Metals soars 289pc on gold and lithium projects update
‘Fully funded’ – MGC Pharma completes share consolidation and ~US$8 million cap raise
‘Unwavering Support’: MGC Pharma secures US$7.9 million from investors as looks to advance US FDA IND applications
In Case You Missed It: A strategic superannuation partnership takes the lead today
Quarterly wrap: YPB metrics continue to improve as it pursues profitability
ASX Small Caps Lunch Wrap: Who’s had their world turned upside down this week?
Top 10 at 11: It’s a pretty quiet morning, but the metal heads want to turn it up loud
Clinical results for ancient therapy help ASX cannabis stocks weed out competition
Top 10 at 11: CCE inks €€€ Irish energy deal, Besra finds gold under the gold it found before
ASX Biotech August Winners: Sector down despite CSL and Cochlear’s strong results, but don’t panic…
Weed Week: ‘Welcome to the psychedelic 2020s!’ as market holds breath on key US approval
